4d Pharma Share Discussion Threads

[don carter] 25/9/2024 11:13

"Your shares are now considered worthless"....Thanks guys, for nothing. And what redress do we have? Nada. What punishment do the directors get? Zilch. Do we have an incentive for backing this type of company again in the UK? None.

[3windy] 05/9/2024 16:28

US stock that looks like a professional version of 4D Pharma. CEO from Nvidia has taken a position. Recursion Pharmaceuticals, Inc. (RXRX)

[nigelpm] 23/4/2024 20:53

Yeah - trade creditors were insane - remember looking at the accounts shortly before they went belly up - insolvent.

[jaknife] 23/4/2024 20:18

The unsecured get about £635k but the total owed to the unsecured is c. £92.1m!

[washingmachine] 23/4/2024 19:33

Shareholders were fraudulently deceived
Have i read it right
None secured are eligible for a minimal dividend ?

[jaknife] 23/4/2024 09:36

An updated administrator's report has been filed at Companies House:

[thanatos abyss] 17/2/2024 13:26

Nobbygnome - 27 Jun 2022 - 20:22:57 - 7621 of 7893
Yet more lies but yes I have a PhD. in immunology!

......

It didn't help here unfortunately. Did the gullible gold to the bitter end?

[glynedwards] 07/8/2023 15:34

Thanks JakNife

[jaknife] 05/8/2023 16:47

FYI, the administrator has filed their report for the six months to 23 June 2023 at Companies House:



The inference is that shareholders will get nothing as the secured creditors are not expected to be repaid in full and the unsecured creditors are not expected to be paid anything.

[swallowsflysouth] 13/7/2023 07:55

found this old article posted on another website. Apparently the creditors are ok, i don't think they mean us. Looks like other investors will gain from the research.

hxxps://www.insidermedia.com/news/yorkshire/4d-pharma-subsidiary-sold-but-uk-and-ireland-jobs-lost#:~:text=A%20Spanish%20subsidiary%20of%20pharmaceutical

[katsy] 23/6/2023 07:07

This Friday last year we were greeted with the news of "temporary Suspension RNS"

[bermudashorts] 26/5/2023 06:58

Abstracts for ASCO were published yesterday and interesting to see that Mark Lythgoe from Imperial College will be presenting a poster at ASCO with phase 1b MRX0518 trial results. It relates to the only MRX0518 clinical trial showing as still active which was looking at MRX0518 in the neoadjuvant setting across multiple solid cancer types.

[katsy] 22/5/2023 10:54

I wonder who keeps ticking down, get over yourself, you've lost all your money here, you were wrong. Ok

[the donald] 13/4/2023 12:55

Worthless. I wrote to the administrator and they replied highly unlikely anything for shareholders.

[ropey] 13/4/2023 12:48

Are the shares now worthless or could they come to life in another form ?

[nigelpm] 29/3/2023 06:17

It's in the public domain and likely a nominal amount. Meaningless to shareholders I would think. They'll end up with nothing.

[jackrussell3] 29/3/2023 05:47

Anything less than a statement from Interpath is fake news.

[pol123] 27/3/2023 11:03

CJ Bioscience announced Monday that it had signed a contract to take over new drug candidates and their platform technology with 4D Pharma, a company based in the United Kingdom and Ireland.

출처 : KBR(hxxps://www.koreabiomed.com)

[millennialinvestor] 21/3/2023 10:05

And f all for investors.